This opportunity is no longer accepting applications.
grant PAR-21-329

Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)

This grant opportunity aims to fund collaborative research projects that study the long-term side effects of cancer treatments, which can become chronic health issues or appear later after treatment. It supports basic, translational, and clinical research to uncover the mechanisms behind these side effects, describe them clinically, and develop ways to prevent or lessen them. The research shou…

The purpose of this Funding Opportunity Announcement (FOA) is to support collaborative research projects designed to address adverse sequelae of cancer therapies that persist and become chronic comorbidities or develop as delayed posttreatment effects. This FOA supports basic, translational, and…

Funding Source

Agency: National Institutes of Health
Program: SBIR

Dates

Opportunity Released: September 22, 2021
Open for Submission: September 22, 2021
Submission Deadline: November 5, 2024
Application Window Closes: November 5, 2024

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.